We observe a prominent increase in apoptosis in SPHINX-treated AML and CML cells, suggesting that SRPK1 plays a central role in the regulation of alternative splicing, presumably by favouring the expression of anti-apoptotic splice isoforms. The gene discussed is SRPK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.